Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial intelligence in early drug discovery enabling precision medicine
Fabio Boniolo, Emilio Dorigatti, Alexander J. Ohnmacht, et al.
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 9, pp. 991-1007
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Game changers in science and technology - now and beyond
Ulrich A. K. Betz, Loukik Arora, R.A. Assal, et al.
Technological Forecasting and Social Change (2023) Vol. 193, pp. 122588-122588
Open Access | Times Cited: 72
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies
Davide Bassani, Stefano Moro
Molecules (2023) Vol. 28, Iss. 9, pp. 3906-3906
Open Access | Times Cited: 55
Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade
Liuying Wang, Yongzhen Song, Hesong Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 253-253
Open Access | Times Cited: 52
Towards revolutionizing precision healthcare: A systematic literature review of artificial intelligence methods in precision medicine
Wafae Abbaoui, Sara Retal, Brahim El Bhiri, et al.
Informatics in Medicine Unlocked (2024) Vol. 46, pp. 101475-101475
Open Access | Times Cited: 26
Role of Artificial Intelligence in Revolutionizing Drug Discovery
Ashfaq Ur Rehman, Mingyu Li, Binjian Wu, et al.
Fundamental Research (2024)
Open Access | Times Cited: 24
The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease
Mohammad R.M. Abu‐Zahra, Abdulla Al‐Taher, Mohamed Alquhaidan, et al.
Drug Metabolism and Personalized Therapy (2024) Vol. 39, Iss. 2, pp. 47-58
Closed Access | Times Cited: 17
Advancing Optical Nanosensors with Artificial Intelligence: A Powerful Tool to Identify Disease-Specific Biomarkers in Multi-omics Profiling
Bakr Ahmed Taha, Zahraa Mustafa Abdulrahm, Ali J. Addie, et al.
Talanta (2025) Vol. 287, pp. 127693-127693
Closed Access | Times Cited: 4
Harnessing the Power of Artificial Intelligence in Pharmaceuticals: Current Trends and Future Prospects
Saha Aritra, Indu Singh
Intelligent Pharmacy (2025)
Open Access | Times Cited: 2
Estrogenic flavonoids and their molecular mechanisms of action
Ryoiti Kiyama
The Journal of Nutritional Biochemistry (2022) Vol. 114, pp. 109250-109250
Open Access | Times Cited: 49
A systematic review of computational approaches to understand cancer biology for informed drug repurposing
Faheem Ahmed, Anupama Samantasinghar, Afaque Manzoor Soomro, et al.
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104373-104373
Open Access | Times Cited: 34
Applications of artificial intelligence in clinical laboratory genomics
Swaroop Aradhya, Flavia M. Facio, Hillery C. Metz, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2023) Vol. 193, Iss. 3
Open Access | Times Cited: 29
Strategies of Artificial intelligence tools in the domain of nanomedicine
Mohammad Habeeb, Huay Woon You, Mutheeswaran Umapathi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105157-105157
Closed Access | Times Cited: 28
From understanding diseases to drug design: can artificial intelligence bridge the gap?
Anju Choorakottayil Pushkaran, Alya A. Arabi
Artificial Intelligence Review (2024) Vol. 57, Iss. 4
Open Access | Times Cited: 15
The Artificial Intelligence-Driven Pharmaceutical Industry: A Paradigm Shift in Drug Discovery, Formulation Development, Manufacturing, Quality Control, and Post-Market Surveillance
Kampanart Huanbutta, Kanokporn Burapapadh, Pakorn Kraisit, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 203, pp. 106938-106938
Open Access | Times Cited: 12
Artificial intelligence for breast cancer: Implications for diagnosis and management
Jehad Feras AlSamhori, Abdel Rahman Feras AlSamhori, Leslie Anne Duncan, et al.
Journal of Medicine Surgery and Public Health (2024) Vol. 3, pp. 100120-100120
Open Access | Times Cited: 10
Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery
Purvashi Pasrija, Prakash Jha, Pruthvi Upadhyaya, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 20, pp. 1692-1727
Closed Access | Times Cited: 36
Decoding the protein–ligand interactions using parallel graph neural networks
Carter Knutson, Mridula Bontha, Jenna A. Bilbrey, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Toward structure–multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective
Edgar López‐López, José L. Medina‐Franco
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104046-104046
Closed Access | Times Cited: 7
Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19
Yi Cong, Toshinori Endo
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 7, pp. 361-371
Open Access | Times Cited: 26
Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine
Ha Ram Kim, Boghos Taslakjian, Sarah Kim, et al.
ChemBioChem (2024) Vol. 25, Iss. 8
Open Access | Times Cited: 5
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Agyemang Kwasi Sampene, Fatuma Nyirenda
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Application of machine learning in the management of lymphoma: Current practice and future prospects
Junyun Yuan, Ya Zhang, Xin Wang
Digital Health (2024) Vol. 10
Open Access | Times Cited: 5
The Applications of Artificial Intelligence (AI)-Driven Tools in Virus-Like Particles (VLPs) Research
Bugude Laxmi, P. Uma Maheswari Devi, Naveen Thanjavur, et al.
Current Microbiology (2024) Vol. 81, Iss. 8
Closed Access | Times Cited: 5
Machine Learning and Deep Learning in Data-Driven Decision Making of Drug Discovery and Challenges in High-Quality Data Acquisition in the Pharmaceutical Industry
Sethu Arun Kumar, T. Durai Ananda Kumar, Narasimha M. Beeraka, et al.
Future Medicinal Chemistry (2021) Vol. 14, Iss. 4, pp. 245-270
Closed Access | Times Cited: 32
3D models of neurodegeneration: implementation in drug discovery
Chloe Whitehouse, Nicola Corbett, Janet Brownlees
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 4, pp. 208-221
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top